{
    "nct_id": "NCT04122196",
    "official_title": "Perioperative Pregabalin as Part of a Multimodal Treatment Plan for Ureteral Stent Symptoms After Ureteroscopy: a Randomized Controlled Trial",
    "inclusion_criteria": "Subject Inclusion:\n\n* Age >= 18 years\n* Subject Population Undergoing elective ureteroscopy with stent placement at University of Missouri Hospital and affiliated facilities\n\nSubject Exclusion:\n\n* Renal insufficiency (eGFR < 60 mL/minute/1.73 m2)\n* Chronic indwelling ureteral stent (>30 days in the previous year)\n* Chronic opioid use\n* History of opioid abuse\n* Chronic gabapentinoid use\n* History of gabapentinoid abuse\n* Plan for inpatient hospitalization\n* Pregnancy\n* Inability of the patient to consent for themselves in English\n* Allergy to gabapentinoid\n* Liver failure or hepatic dysfunction\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}